MACROGENICS, INC. Increase (Decrease) in Other Noncurrent Liabilities
MACROGENICS, INC. (MGNX) reported Increase (Decrease) in Other Noncurrent Liabilities of -$600.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-08-14
- MACROGENICS, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-06-30 was -$276.00K.
- MACROGENICS, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-03-31 was -$324.00K.
- MACROGENICS, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-09-30 was -$340.00K.
- MACROGENICS, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-06-30 was -$300.00K.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month |
|---|---|---|---|
| 2026-06-30 | -$276.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$600.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$324.00K 10-Q · filed 2026-05-13 | ||
| 2025-09-30 | -$340.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$640.00K derived: sum of 2 quarters · filed 2026-08-14 | -$640.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | -$300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$300.00K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-13 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |